Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

CytRx

NASDAQ CYTR
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 19 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

6.62M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-3.38M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.18
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
36.78M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events CytRx

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart CytRx

Stock analysis CytRx

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-1.00 28.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
0.75 4.35
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
0.51 10.00
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
1.50 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-102.27 7.67

Price change CytRx per year

0.52$ 4.25$
Min Max

Summary analysis CytRx

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure CytRx

Revenue and net income CytRx

All parameters

Stock news CytRx

All news

About company CytRx

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed cytotoxin agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor. It also provides ACDx, an albumin companion diagnostic product to identify patients with cancer who are most likely to benefit from treatment with these drug candidates. CytRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.
Address:
Company name: CytRx
Issuer ticker: CYTR
Country: USA
Exchange: NASDAQ
Currency: $
Sector: Healthcare
Industry: Biotechnology
Site:

On which stock exchange are CytRx (CYTR) stocks traded?

CytRx (CYTR) stocks are traded on NASDAQ.

What is the ticker of CytRx stocks (CYTR)?

The stock ticker of CytRx’s stocks or in other words, the code is CYTR. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does CytRx (CYTR) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, CytRx (CYTR) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are CytRx (CYTR) stocks traded?

CytRx (CYTR) stocks are traded on the NASDAQ exchange in dollars.

What is the price of CytRx (CYTR) stocks today?

The current price of CytRx stocks on 19.05.2024 is dollars. per share.

What is the dynamics of CytRx (CYTR) stocks from the beginning of the year?

CytRx (CYTR) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did CytRx (CYTR) stocks increase in мае 2024?

This month CytRx (CYTR) quotes have increased by 0% to dollars. per share.

How much are CytRx (CYTR) stocks worth?

Today, on October, 19.05.2024 CytRx’s (CYTR) stocks cost dollars..

What is the market capitalization of CytRx (CYTR)?

Capitalization is the market value of CytRx (CYTR) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of CytRx (CYTR) is estimated at about 6620407 dollars.